Close Menu
    What's Hot

    Record Low Mortality Rates So Far in England and Wales in 2026

    July 9, 2026

    Optimism for Stronger Second Half in the Life Settlement Tertiary Market

    July 8, 2026

    Organ Transplant Improvements Test Life Expectancy Assessment Models

    July 8, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Big Year of Growth for Life/Annuity Sidecar-Like Activity in 2025

      July 2, 2026

      Pacific Life Re Appoints Florence Durousseau as Head of Capital Solutions, Europe

      June 15, 2026

      Third Block Reinsurance Deal With Tokio Marine & Nichido Life for Pacific Life Re

      June 10, 2026

      Lumos Insurance Hires Tom Kenny To Establish Reinsurance Operations

      June 9, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      STS Field Grant Limited Pension Scheme Completes Bulk Purchase Annuity Buy-In With Aviva

      July 6, 2026

      Associated Board of the Royal Schools of Music Pension Scheme Completes Bulk Purchase Annuity Buy-In With PIC

      July 2, 2026

      First Quarter US Pension Risk Transfer Sales Down Almost Half Compared to 2025

      July 2, 2026

      Constellation Institutional Markets Re-Enters Pension Risk Transfer Market

      July 2, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      Optimism for Stronger Second Half in the Life Settlement Tertiary Market

      July 8, 2026

      US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

      July 8, 2026

      UK Equity Release Market Waits on Fourth Quarter for Potentially Market-Altering Change

      June 24, 2026

      Q&A: James Westerlind, Partner, ArentFox Schiff

      June 24, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Optimism for Stronger Second Half in the Life Settlement Tertiary Market

      July 8, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

      July 8, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    US Life Insurers’ Ample Capital, Liquidity to Support Ratings in 2026

    Life Insurance February 25, 2026By Jamie Tucker and Jack Rosen
    Share
    Twitter LinkedIn Email

    Fitch Ratings has a ‘neutral’ outlook for North American life insurers for 2026 despite a more challenging backdrop, as strong capital, prudent asset/liability management, and liquidity will help issuers to withstand declining policy rates, slowing economic growth, heightened macroeconomic volatility, and geopolitical uncertainty. 

    Stability of operating earnings, net investment income and return on equity will be supported by increasing assets under management, improving fixed-income returns, and spread widening that will be partially offset by policy rate declines and equity market volatility. US life insurers are exposed to changes in interest rates, though the sector’s closely matched assets and liabilities partially mitigate impacts. 

    We expect a modest increase in credit losses YoY and will continue to monitor investment quality and underwriting for signs of late cycle behavior and outsized risk taking. In the event of a more severe market downturn, which is not in our base case, insurers’ strong capitalization will partially insulate balance sheets. 

    Commercial real estate (CRE) exposure, notably in office properties, will remain under pressure, though it is abating, driven by increased transactions and lower interest rates. Insurers’ credit loss reserves have increased meaningfully, reflecting the challenging dynamics, which should absorb the expected uptick in realized losses. 

    We expect investment risk for the industry to increase modestly in 2026, with growth in offshore reinsurance and partnerships with alternative investment managers (Alt IMs) to persist. US life insurers looking for higher yields and longer-term returns have raised their allocations to private credit and Level III assets but are not expected to face widespread rating pressure if private credit performance weakens over the next 12-24 months. Alt IM partnerships will be tilted towards strategic partnerships, minority stakes, reinsurance platforms and sidecars, with most large Alt IMs having an insurance platform in place. 

    Figure 1: US Life Insurer Yields and Spreads 

    Source: Fitch Ratings, company financials, BofA Merrill Lynch, FRB St. Louis. 

    The continued shift toward less-liquid investments will increase regulatory scrutiny to ensure that the capital held is commensurate with risk. The focus on private credit will increase, particularly among bank and insurance regulators, given the potential spillover risks from the growing interconnectedness among market participants. The National Association of Insurance Commissioners in the United States and the Bermuda Monetary Authority have proposed and adopted initiatives, such as strengthening disclosure granularity and capital requirements, to increase transparency and resilience and protect policyholder obligations. 

    Figure 2: Offshore and Alt. IM Reinsurance Growth (Reserve Credit and Modified Coinsurance Reserves) 

    Source: Fitch Ratings, company financials, S&P Capital IQ Pro 

    The rapid growth of private letter ratings (PLRs) raises risks for US life insurers as the industry increases exposure to more complex, opaque investments untested by a macroeconomic downturn. Key watch items include effectiveness of impending regulation, percentage of capital invested in PLR-rated issuers, illiquidity, and valuation methodologies regarding governance, subjectivity, reliability, and transparency. 

    Positive market conditions have supported record issuance of funding asset backed notes (FABNs), with increased issuer participation and investor demand. Robust issuance should continue in 2026, the volume and pace of which will depend on the path of interest rate cuts and credit spreads. Due to their credit sensitivity, rate exposure and commoditized nature, FABNs introduce incremental risk compared to traditional insurance liabilities, with outsized issuance levels marginally increase credit risk in a benign but volatile environment. 

    Figure 3: US Life Insurer FABN Issuance (USD $bn) 

    Source: Fitch Ratings, Bloomberg Financial. 
     
    We expect offshore (re)insurance activity to continue growing in 2026 as insurers seek to increase reported capital and earnings via spread-based transactions. This can elevate counterparty credit risk. Fitch evaluates reported capital using the Prism capital model on a consolidated basis, which limits the scope for regulatory arbitrage to affect assessed capital strength and credit profiles. 

    Jamie Tucker, CFA, CPA is a Senior Director in the Insurance Team at Fitch Ratings 

    Jack Rosen is a Director in the Insurance Team at Fitch Ratings

    Any views expressed in this article are those of the author(s) and may not necessarily represent those of Longevity & Mortality Investor or its publisher, the European Life Settlement Association

    2026 - February Commentary Longevity Risk Mortality Risk Volume 2 Issue 3 – March 2026
    Share. Twitter LinkedIn Email

    Related Posts

    Optimism for Stronger Second Half in the Life Settlement Tertiary Market

    July 8, 2026By Greg Winterton

    Passage of UK Pension Schemes Act Seen Boosting Size of DB Superfund Market

    June 24, 2026By Mark McCord

    UK Equity Release Market Waits on Fourth Quarter for Potentially Market-Altering Change

    June 24, 2026By Greg Winterton

    From Policy Ambition to Operational Reality: Building the Foundations of the UK’s Next Pensions Era

    June 24, 2026By Peter Roos
    Latest Issue

    Optimism for Stronger Second Half in the Life Settlement Tertiary Market

    July 8, 2026

    Organ Transplant Improvements Test Life Expectancy Assessment Models

    July 8, 2026

    US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

    July 8, 2026

    Passage of UK Pension Schemes Act Seen Boosting Size of DB Superfund Market

    June 24, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.